跳至主要内容
临床试验/EUCTR2008-001502-17-IT
EUCTR2008-001502-17-IT进行中(未招募)不适用

MULTICENTRIC COMPARATIVE RANDOMIZED DOUBLE BLIND CROSS OVER STUDY WITH TACROLIMUS (FK506)0.1% EYEDROPS AND CYCLOSPORINE 1% EYEDROPS IN CHILDREN WITH SEVERE ACTIVE VERNAL KERATOCONJUNCTIVITIS, LASTING 7 WEEKS, FOLLOWED BY AN OPEN TRIAL LASTING 24 MONTHS TO EVALUATE LONG TERM EFFICACY AND SAFETY OF THE TREATMENT - ND

AZIENDA OSPEDALIERA MEYER0 个研究点开始时间: 2008年3月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Active VKC - At least 6 months from the start of VKC - Objective score of 7 points or more - No substantial decrease in sign and symptoms of VKC after at least 15 days of topical treatment with cyclosporine
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - age < 2 years - Immunodeficiency - Neoplasms - Chronic infectious diseases - Active corneal ulcer(s)

研究者

发起方
AZIENDA OSPEDALIERA MEYER

相似试验